Sentien Biotechnologies Featured in FierceBiotech

Sentien Biotechnologies was featured in FierceBiotech on April 17, 2017.  In the article, Sentien co-founder Biju Parekkadan discusses the company’s recent $12M Series A round, the technology behind Sentien’s lead product, and the upcoming clinical trial of the product in acute kidney injury patients.  Read more here.